Chinese Journal of Cancer Research

Papers
(The H4-Index of Chinese Journal of Cancer Research is 15. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)
ArticleCitations
Molecular features of gastroenteropancreatic neuroendocrine carcinoma: A comparative analysis with lung neuroendocrine carcinoma and digestive adenocarcinomas54
Efficacy and safety of low-dose cyclophosphamide combined with lenvatinib, pembrolizumab and TACE for unresectable hepatocellular carcinoma: A single-center, prospective, single-arm clinical trial49
Gastric cancer surgery in South Korea: Past, present, and future33
Efficacy of ctDNA methylation combined with traditional detection modality to detect liver cancer among high-risk patients: A multicenter diagnostic trial32
Transforming cancer cells for long-term living with cancer: An inspiring new approach30
Focal ablation therapy presents promising results for selectively localized prostate cancer patients28
Heterogeneity of tumor-infiltrating myeloid cells in era of single-cell genomics28
National guidelines for diagnosis and treatment of thyroid cancer 2022 in China (English version)27
Microbiota and urinary tumor immunity: Mechanisms, therapeutic implications, and future perspectives26
Detection and classification of breast lesions using multiple information on contrast-enhanced mammography by a multiprocess deep-learning system: A multicenter study24
Mn-based cGAS-STING activation for tumor therapy23
Sequential neoadjuvant chemotherapy using pegylated liposomal doxorubicin and cyclophosphamide followed by taxanes with complete trastuzumab and pertuzumab treatment for HER2-positive breast cancer: A23
Prophylactic hyperthermic intraperitoneal chemotherapy in patients with locally advanced gastric cancer after curative surgery: Final results of a phase II trial22
Adjuvant tamoxifen switched to exemestane treatment in postmenopausal women with estrogen receptor-positive early breast cancer: A pragmatic, multicenter, and prospective clinical trial in China21
New roles of tumor-derived exosomes in tumor microenvironment19
0.49849891662598